- জেনেরিক নাম
- Rifampicin
- শক্তি
- 450 mg
- ডোজ ফর্ম
- Capsule
- প্রস্তুতকারক
- G. A. Company Ltd.
Rifatan Capsule
Rifatan 450 mg Capsule সম্পর্কে
Rifatan হলো Rifampicin-এর একটি ব্র্যান্ড, শক্তি ৪৫০ mg, ক্যাপসুল আকারে। Rifatan প্রস্তুত করেছে G. A. Company Ltd। Rifampicin-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Rifampicin-এর ১৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Firifam 150 mg Tablet-এর, প্রতি ইউনিট ৳ ১।
Rifatan 450 mg Capsule কী?
Rifatan 450 mg Capsule is a medicine with the active ingredient rifampicin, which belongs to a group called anti-tubercular antibiotics. It works by stopping the bacteria that cause tuberculosis and meningococcal infections from making proteins they need to survive. Doctors prescribe it as part of a combination regimen for tuberculosis, and sometimes to eliminate meningococcal bacteria in people who carry them without being ill. The capsule is taken by mouth, usually on an empty stomach. Because rifampicin can interact with many other medicines and affect the liver, it should only be used under medical supervision. The dose and duration are set by the doctor based on the patient's condition.
Rifatan-এর ব্যবহার
Rifatan 450 mg Capsule is used to treat tuberculosis, an infection caused by Mycobacterium tuberculosis. It is always given with other anti-tuberculosis medicines, never alone, to prevent resistance. It is also used to treat people who carry meningococcal bacteria in their nose and throat without being sick, to stop the spread of meningococcal disease. Your doctor will confirm the infection before starting treatment. The medicine is not for treating viral infections like colds or flu.
Rifatan কীভাবে ব্যবহার করবেন
Take Rifatan 450 mg Capsule exactly as your doctor tells you. The capsule is swallowed whole with a full glass of water. It is usually taken once a day, either one hour before or two hours after a meal, but follow your doctor's instructions. Do not chew or open the capsule. If you forget a dose, take it as soon as you remember, unless it is almost time for the next dose; do not double up. Complete the full course even if you feel better, and do not stop without talking to your doctor.
Rifatan-এর পার্শ্বপ্রতিক্রিয়া
Common side effects of rifampicin include facial flushing, itching, rash, nausea, vomiting, loss of appetite, diarrhoea, and stomach discomfort. It may cause a flu-like syndrome with fever, chills, headache, dizziness, bone pain, and shortness of breath. Body fluids such as urine, sweat, saliva, tears, and faeces may turn orange-red; this is expected and harmless. Serious effects include liver problems, blood disorders, kidney problems, and severe skin reactions. Contact your doctor if you notice yellowing of the eyes or skin, dark urine, severe tiredness, or any unusual bleeding or bruising.
সতর্কতা ও নিরাপত্তা
Before using Rifatan 450 mg Capsule, tell your doctor if you have liver disease, kidney problems, or any allergies, especially to rifampicin or similar antibiotics. This medicine can cause liver damage, so your doctor may monitor your liver function. It interacts with many medicines, including some antivirals, anticoagulants, and oral contraceptives, so inform your doctor about all medicines you take. Do not take antacids at the same time. In pregnancy, rifampicin may cause bleeding problems in the mother and newborn if taken near delivery; discuss with your doctor. Breastfeeding mothers should consult their doctor. Alcohol may increase the risk of liver problems. The doctor will decide if this medicine is suitable for you.
সাধারণ প্রশ্ন
How should I store Rifatan 450 mg Capsule?
Store it between 15°C and 30°C, away from excessive heat and light. Keep it in the original container, tightly closed, and out of reach of children. Do not use it after the expiry date printed on the pack. Do not store it in the bathroom or near a sink.
What is Rifatan 450 mg Capsule used for and what kind of medicine is it?
It is an anti-tubercular antibiotic used to treat tuberculosis, always in combination with other medicines. It is also used to clear meningococcal bacteria from carriers. It works by blocking the bacteria's ability to make proteins. It is not for viral infections.
What does the dosage form and strength mean?
Rifatan comes as a capsule, a solid dosage form that you swallow with water. The strength is 450 mg, meaning each capsule contains 450 milligrams of the active ingredient, rifampicin. Your doctor will decide how many capsules you need and for how long, based on your condition.
Can I take Rifatan with other medicines?
Rifampicin interacts with many medicines, including some antivirals, blood thinners, and oral contraceptives, and can make them less effective. Always tell your doctor or pharmacist about all medicines, supplements, and herbal products you are taking before starting Rifatan. Do not start any new medicine without checking first.
আরও পাওয়া যায়
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the ... Read moreIn the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampinand they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regimen should be modified.ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rifampicin suppresses initiation of chain formation for RNA synthesis in susceptible bacteria by binding to the β subunit of DNA-dependent RNA polymerase, thus blocking RNA transcription.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rifampin can be administered by the oral route or by IV infusion. IV doses are the same as those for oral.Tuberculosis:
- Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
- Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.
Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
May accelerate the metabolism and reduce the effect of drugs that are metabolised by CYP450 enzymes (e.g. quinidine, phenytoin, theophylline). Decreased concentrations of atovaquone and increased concentrations of rifampicin when taken concomitantly. Concurrent use of ketoconazole and rifampicin may result in decreased serum concentrations of both drugs. May decrease serum concentrations of enalaprilat. Reduced absorption by antacids. Increased risk of hepatotoxicity with halothane or isoniazid.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rifampicin is contraindicated in patients with a history of hypersensitivity to rifampin or any of the components, or to any of the rifamycins. Rifampin is contraindicated in patients who are also receiving ritonavir-boosted saquinavir due to an increased risk of severe hepatocellular toxicity.Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.
পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Facial flushing and itching, with or without a rash, flu-like syndrome characterised by episodes of fever, chills, headache, dizziness, bone pain, shortness of breath, and malaise; GI adverse effects (e.g. nausea, vomiting, anorexia, diarrhoea, epigastric distress), pseudomembranous colitis, eosinophilia, leucopenia, haemolytic anaemia; alterations in kidney function and renal failure, menstrual disturbances, oedema, myopathy, muscular weakness; orange-red discolouration of the urine, faeces, sweat, saliva, sputum, tears, and other body fluids; thrombophlebitis, local irritation and inflammation after prolonged IV infusion. Rarely, eye irritation and visual disturbances, anaphylaxis or shock.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy: When administered during the last few weeks of pregnancy, rifampin can cause post natal hemorrhages in the mother and infant for which treatment with vitamin K may be indicated.Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rifampicin has been shown to produce liver dysfunction. Fatalities associated with jaundice have occurred in patients with liver disease and in patients taking rifampin with other hepatotoxic agents. Patients with impaired liver function should be given rifampin only in cases of necessity and then with caution and under strict medical supervision. In these patients, careful monitoring of liver function, especially SGPT/ALT and SGOT/AST should be carried out prior to therapy and then every 2 to 4 weeks during therapy. If signs of hepatocellular damage occur, rifampin should be withdrawn.In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.
Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.
মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nausea, vomiting, abdominal pain, pruritus, headache, and increasing lethargy will probably occur within a short time after ingestion; unconsciousness may occur when there is severe hepatic disease. Transient increases in liver enzymes and/or bilirubin may occur. Brownish-red or orange discoloration of the skin, urine, sweat, saliva, tears, and feces will occur, and its intensity is proportional to the amount ingested.Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.
Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.
সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store between 15-30° C. Avoid excessive heat and protect from light.বিকল্প ব্র্যান্ড: Rifampicin
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।